Cormorant Asset Management LP 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-16 3:09 pm Sale |
2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Cormorant Asset Management LP | 0 0.000% |
-1,144,537![]() (Position Closed) |
Filing |
2020-04-27 4:05 pm Purchase |
2020-04-16 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Cormorant Asset Management LP | 1,144,537 5.760% |
1,144,537![]() (New Position) |
Filing |